Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1441, 2004-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Access to resources
Recommend
Long-term androgen suppression impact on QOL "acceptable"
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. :
Long-term somatropin therapy promotes growth in paediatric patients
Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. :
Enfuvirtide-based treatment provides long-term benefit
Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. :
Long-term somatropin: benefit in idiopathic isolated GH deficiency?
Inpharma, Vol. 1, Iss. 1347, 2002-01 ,pp. :